EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-SA 4.0

Transformative Results in Giant Pyoderma Gangrenosum with Dexamethasone-cyclophosphamide Pulse

Avinash Jadhav, Jahanvi Goyal, Amit Girme, Kirti Shrikant Deo

Annals of African Medicine · 2025

DOI: 10.4103/aam.aam_223_24 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of African Medicine, 2025. Verfasst von Avinash Jadhav und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Dr. D. Y. Patil Medical College and Hospital, Pune, Maharashtra, India. Hauptthemen laut MEDLINE: Cyclophosphamide, Dexamethasone, Glucocorticoids, Immunosuppressive Agents. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pyoderma gangrenosum (PG) is a cutaneous ulcerative condition that can present in various forms, including ulcerative, bullous, pustular, vegetative, and peristomal. It often occurs and recurs in areas subjected to trauma due to the pathergy phenomenon, where irritation or injury triggers flare-ups. The condition typically begins as a painful erythematous lesion that rapidly progresses to a necrotic or blistering ulcer. PG is commonly associated with systemic conditions such as rheumatologic diseases, paraproteinemia, inflammatory bowel disease, and hematologic cancers. Active or poorly controlled PG can result in significant morbidity, including severe pain, loss of mobility, and anemia of chronic disease. Diagnosis is primarily clinical, and treatment is generally focused on systemic corticosteroids. Complete healing may take months, with ongoing maintenance therapy. However, long-term immunosuppression can lead to various adverse effects. Despite recent therapeutic advances, the prognosis of pyoderma gangrenosum remains unpredictable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclophosphamideDexamethasoneGlucocorticoidsImmunosuppressive AgentsPyoderma GangrenosumHumansMaleTreatment OutcomeAdult

Stichwörter der Autor:innen

Dexamethasone-cyclophosphamide pulsePouls de dexaméthasone-cyclophosphamidepyoderma gangrenosumulcerulcère

Substanzen

CyclophosphamideDexamethasoneGlucocorticoidsImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Dermatology, Dr. D. Y. Patil Medical College and Hospital, Pune, Maharashtra, India.
  • Department of General Surgery, Dr. D. Y. Patil Medical College and Hospital, Pune, Maharashtra, India.

Zitieren

APA

Jadhav, A., Goyal, J., Girme, A., & Deo, K. S. (2025). Transformative Results in Giant Pyoderma Gangrenosum with Dexamethasone-cyclophosphamide Pulse. Annals of African Medicine. https://doi.org/10.4103/aam.aam_223_24

Vancouver

Jadhav A, Goyal J, Girme A, Deo KS. Transformative Results in Giant Pyoderma Gangrenosum with Dexamethasone-cyclophosphamide Pulse. Annals of African Medicine. 2025. doi:10.4103/aam.aam_223_24

BibTeX
@article{Jadhav2025,
  author = {Jadhav, Avinash and Goyal, Jahanvi and Girme, Amit and Deo, Kirti Shrikant},
  title = {Transformative Results in Giant Pyoderma Gangrenosum with Dexamethasone-cyclophosphamide Pulse},
  journal = {Annals of African Medicine},
  year = {2025},
  doi = {10.4103/aam.aam_223_24}
}
Kostenlos starten →